A336040 Stock Overview
TASCOM Co.,Ltd. manufactures and distributes diabetic supplies in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
TASCOM Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩4,830.00 |
52 Week High | ₩14,920.00 |
52 Week Low | ₩3,700.00 |
Beta | 0 |
1 Month Change | -37.19% |
3 Month Change | -49.69% |
1 Year Change | -59.48% |
3 Year Change | -77.27% |
5 Year Change | n/a |
Change since IPO | -76.38% |
Recent News & Updates
Recent updates
Shareholder Returns
A336040 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | -1.0% | 6.0% | 3.1% |
1Y | -59.5% | 39.8% | 13.4% |
Return vs Industry: A336040 underperformed the KR Medical Equipment industry which returned 39.8% over the past year.
Return vs Market: A336040 underperformed the KR Market which returned 13.4% over the past year.
Price Volatility
A336040 volatility | |
---|---|
A336040 Average Weekly Movement | 9.8% |
Medical Equipment Industry Average Movement | 6.5% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A336040's share price has been volatile over the past 3 months.
Volatility Over Time: A336040's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | n/a | https://www.yidobio.com |
TASCOM Co.,Ltd. manufactures and distributes diabetic supplies in South Korea. Its products include blood glucose measurement system-acuraview, BD ultra fine PRO pen needle, syringes-BD ultrafine syringes, Ido sharp container, and Ido safety lancet.
TASCOM Co., Ltd. Fundamentals Summary
A336040 fundamental statistics | |
---|---|
Market cap | ₩19.03b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A336040 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A336040 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A336040 perform over the long term?
See historical performance and comparison